These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 21654556

  • 1. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan.
    Galuppo M, Nocentini G, Mazzon E, Ronchetti S, Esposito E, Riccardi L, Di Paola R, Bruscoli S, Riccardi C, Cuzzocrea S.
    Shock; 2011 Sep; 36(3):263-71. PubMed ID: 21654556
    [Abstract] [Full Text] [Related]

  • 2. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G, Mazzon E, Genovese T, Di Paola R, Caminiti R, Esposito E, Bramanti P, Cuzzocrea S.
    Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
    [Abstract] [Full Text] [Related]

  • 3. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Di Paola R, Esposito E, Mazzon E, Genovese T, Muià C, Crisafulli C, Malleo G, Sessa E, Meli R, Cuzzocrea S.
    Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
    [Abstract] [Full Text] [Related]

  • 4. Role of interleukin-6 in a non-septic shock model induced by zymosan.
    Cuzzocrea S, de Sarro G, Costantino G, Mazzon E, Laurà R, Ciriaco E, de Sarro A, Caputi AP.
    Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
    [Abstract] [Full Text] [Related]

  • 5. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Caminiti R, Esposito E, Di Bella P, Cuzzocrea S.
    Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
    [Abstract] [Full Text] [Related]

  • 6. Genetic and pharmacological inhibition of GITR-GITRL interaction reduces chronic lung injury induced by bleomycin instillation.
    Cuzzocrea S, Ronchetti S, Genovese T, Mazzon E, Agostini M, Di Paola R, Esposito E, Muià C, Nocentini G, Riccardi C.
    FASEB J; 2007 Jan; 21(1):117-29. PubMed ID: 17135359
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
    Jansen MJ, Hendriks T, de Man BM, van der Meer JW, Goris RJ.
    Cytokine; 1999 Sep; 11(9):713-21. PubMed ID: 10479408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury.
    Nocentini G, Cuzzocrea S, Genovese T, Bianchini R, Mazzon E, Ronchetti S, Esposito E, Rosanna DP, Bramanti P, Riccardi C.
    Mol Pharmacol; 2008 Jun; 73(6):1610-21. PubMed ID: 18322000
    [Abstract] [Full Text] [Related]

  • 10. Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice.
    Mondello S, Galuppo M, Mazzon E, Italiano D, Mondello P, Aloisi C, Cuzzocrea S.
    Eur J Pharmacol; 2011 May 01; 658(1):28-40. PubMed ID: 21349270
    [Abstract] [Full Text] [Related]

  • 11. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
    Mazzon E, Esposito E, Di Paola R, Impellizzeri D, Bramanti P, Cuzzocrea S.
    Pharmacol Res; 2011 Jul 01; 64(1):68-79. PubMed ID: 21193041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
    Ferrer TJ, Webb JW, Wallace BH, Bridges CD, Palmer HE, Robertson RD, Cone JB.
    J Surg Res; 1998 Jul 01; 77(2):157-64. PubMed ID: 9733603
    [Abstract] [Full Text] [Related]

  • 14. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
    Tanriverdi P, Yuksel BC, Rasa K, Guler G, Iskit AB, Guc MO, Korkmaz A.
    J Surg Res; 2005 Mar 01; 124(1):67-73. PubMed ID: 15734481
    [Abstract] [Full Text] [Related]

  • 15. Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
    Impellizzeri D, Mazzon E, Di Paola R, Paterniti I, Bramanti P, Cuzzocrea S.
    Free Radic Res; 2011 Jul 01; 45(7):820-34. PubMed ID: 21623687
    [Abstract] [Full Text] [Related]

  • 16. A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.
    Jansen MJ, Hendriks T, Hermsen R, Van der Meer JW, Goris RJ.
    Cytokine; 1998 Nov 01; 10(11):904-10. PubMed ID: 9878128
    [Abstract] [Full Text] [Related]

  • 17. Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.
    Lacal PM, Petrillo MG, Ruffini F, Muzi A, Bianchini R, Ronchetti S, Migliorati G, Riccardi C, Graziani G, Nocentini G.
    J Pharmacol Exp Ther; 2013 Oct 01; 347(1):164-72. PubMed ID: 23892569
    [Abstract] [Full Text] [Related]

  • 18. THE PROTECTIVE ROLE OF CURCUMIN IN ZYMOSAN-INDUCED MULTIPLE ORGAN DYSFUNCTION SYNDROME IN MICE.
    Liu S, Zhang J, Pang Q, Song S, Miao R, Chen W, Zhou Y, Liu C.
    Shock; 2016 Feb 01; 45(2):209-19. PubMed ID: 26555741
    [Abstract] [Full Text] [Related]

  • 19. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
    Dugo L, Chatterjee PK, Mazzon E, McDonald MC, Paola RD, Fulia F, Caputi AP, Thiemermann C, Cuzzocrea S.
    Intensive Care Med; 2002 Jun 01; 28(6):775-88. PubMed ID: 12107686
    [Abstract] [Full Text] [Related]

  • 20. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
    Ozel H, Yuksel BC, Berkem H, Avsar FM, Guler G, Iskit AB, Guc MO, Hengirmen S.
    Eur Surg Res; 2009 Jun 01; 43(2):211-8. PubMed ID: 19556797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.